Humana Inc. (NYSE:HUM) Q4 2025 Earnings Call Transcript February 11, 2026 Humana Inc. misses on earnings expectations.

2026 outlook -- EBITDA -- Full-year EBITDA guidance is $2.05 billion to $2.15 billion, representing 3%-8% comparable currency-neutral growth; productivity and efficiency gains are expected to fund ...

ACV (Annual Contract Value): The total annualized value of newly signed customer contracts, often used as a forward-looking sales or pipeline metric for BPO and IT services companies.

SRT: Superficial Radiation Therapy, a low-energy radiation-based technology used for noninvasive skin cancer treatment. IGSRT ...

Matt Moschner: 2025 marked a return to profitable growth for Cognex Corporation. This includes the divestment of a ...

Heart failure affects 6.7 million Americans, many of whom remain symptomatic despite optimal medical therapy. Kevin Hykes: when taken compliantly, it does very little to improve how patients actually ...

Wu’s innovation won the top prize of $25,000 at the 2025 Thermo Fisher Scientific Junior Innovators Challenge. Hosted by the Society for Science since 1999, it is the nation’s leading STEM competition ...